Medtronic - Comparative Multiple Analysis

Medtronic (Comparative Multiple Analysis)

Home Comparative Index Medtronic

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Link to services page

placeholder_large_analysis.png

Improve your investment analysis with by seeing the Medtronic's Discounted Cash Flow analysis, Medtronic's Warren Buffet analysis, and Medtronic's Weighted Average Cost of Capital (WACC) Analysis.

Notes on the Comparative Multiple Analysis of Medtronic

WikiWealth compares Medtronic's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Medtronic's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Medtronic.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Medtronic's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Medtronic's Analysis


How does this work? The Comparative Investment Analysis determines the value of Medtronic by comparing Medtronic financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Medtronic.

See the Medtronic cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Medtronic.

Also, see the Medtronic's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Medtronic's valuation conclusion for a quick summary.